Skip to main content

Table 7 Dynamic risk rates: rates that could be applied to the relevant stage being valued as a function of WACC and ROI (risk rates are indicated from their status in development to reimbursement)

From: A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-specific clinical success rates

New risk rate CVD by phase
StatusCVD-specific phase rateEndo/Meta-specific phase rate
Pre ph III39.5933.4
Pre ph I51.5949.99
Pre ph I56.4754.5
Discovery58.0656.84